Cellular Dynamics International says it has signed a Center of Excellence agreement with AstraZeneca to speed the pace of drug discovery by using CDI’s stem cell lines and tissue cells.

It is the third Center of Excellence agreement with a major, global pharmaceutical company for CDI, the Madison company founded by UW-Madison stem cell pioneer James Thomson.

“These partnerships show customer recognition that leveraging CDI’s technical expertise and resources can help accelerate their discoveries,” said CDI chief executive Bob Palay.

Financial terms of the agreement were not disclosed.

0
0
0
0
0

Judy Newman is a business reporter for the Wisconsin State Journal.